Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals
Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems....
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Paris
OECD Publishing
2000
|
| Schriftenreihe: | OECD Labour Market and Social Policy Occasional Papers
no.40 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ... |
| Beschreibung: | 1 Online-Ressource (100 p.) 21 x 29.7cm. |
| DOI: | 10.1787/323807375536 |
Internformat
MARC
| LEADER | 00000cam a22000002 4500 | ||
|---|---|---|---|
| 001 | ZDB-13-SOC-061271608 | ||
| 003 | DE-627-1 | ||
| 005 | 20231204121024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210204s2000 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1787/323807375536 |2 doi | |
| 035 | |a (DE-627-1)061271608 | ||
| 035 | |a (DE-599)KEP061271608 | ||
| 035 | |a (FR-PaOEC)323807375536 | ||
| 035 | |a (EBP)061271608 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jacobzone, Stephane |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Pharmaceutical Policies in OECD Countries |b Reconciling Social and Industrial Goals |c Stephane, Jacobzone |
| 264 | 1 | |a Paris |b OECD Publishing |c 2000 | |
| 300 | |a 1 Online-Ressource (100 p.) |c 21 x 29.7cm. | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a OECD Labour Market and Social Policy Occasional Papers |v no.40 | |
| 520 | |a Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ... | ||
| 650 | 4 | |a Social Issues/Migration/Health | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-13-SOC |q FWS_PDA_SOC |u https://doi.org/10.1787/323807375536 |3 Volltext |
| 912 | |a ZDB-13-SOC | ||
| 912 | |a ZDB-13-SOC | ||
| 951 | |a BO | ||
| 912 | |a ZDB-13-SOC | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-13-SOC-061271608 |
|---|---|
| _version_ | 1804748656405905408 |
| adam_text | |
| any_adam_object | |
| author | Jacobzone, Stephane |
| author_facet | Jacobzone, Stephane |
| author_role | aut |
| author_sort | Jacobzone, Stephane |
| author_variant | s j sj |
| building | Verbundindex |
| bvnumber | localFWS |
| collection | ZDB-13-SOC |
| ctrlnum | (DE-627-1)061271608 (DE-599)KEP061271608 (FR-PaOEC)323807375536 (EBP)061271608 |
| discipline | Wirtschaftswissenschaften |
| doi_str_mv | 10.1787/323807375536 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02106cam a22003372 4500</leader><controlfield tag="001">ZDB-13-SOC-061271608</controlfield><controlfield tag="003">DE-627-1</controlfield><controlfield tag="005">20231204121024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210204s2000 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/323807375536</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627-1)061271608</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP061271608</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(FR-PaOEC)323807375536</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EBP)061271608</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jacobzone, Stephane</subfield><subfield code="e">VerfasserIn</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical Policies in OECD Countries</subfield><subfield code="b">Reconciling Social and Industrial Goals</subfield><subfield code="c">Stephane, Jacobzone</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (100 p.)</subfield><subfield code="c">21 x 29.7cm.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Labour Market and Social Policy Occasional Papers</subfield><subfield code="v">no.40</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ...</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Issues/Migration/Health</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="q">FWS_PDA_SOC</subfield><subfield code="u">https://doi.org/10.1787/323807375536</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">BO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-13-SOC-061271608 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-16T15:07:21Z |
| institution | BVB |
| language | English |
| open_access_boolean | |
| owner | DE-863 DE-BY-FWS |
| owner_facet | DE-863 DE-BY-FWS |
| physical | 1 Online-Ressource (100 p.) 21 x 29.7cm. |
| psigel | ZDB-13-SOC |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | OECD Publishing |
| record_format | marc |
| series2 | OECD Labour Market and Social Policy Occasional Papers |
| spelling | Jacobzone, Stephane VerfasserIn aut Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Stephane, Jacobzone Paris OECD Publishing 2000 1 Online-Ressource (100 p.) 21 x 29.7cm. Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier OECD Labour Market and Social Policy Occasional Papers no.40 Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ... Social Issues/Migration/Health FWS01 ZDB-13-SOC FWS_PDA_SOC https://doi.org/10.1787/323807375536 Volltext |
| spellingShingle | Jacobzone, Stephane Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Social Issues/Migration/Health |
| title | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals |
| title_auth | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals |
| title_exact_search | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals |
| title_full | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Stephane, Jacobzone |
| title_fullStr | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Stephane, Jacobzone |
| title_full_unstemmed | Pharmaceutical Policies in OECD Countries Reconciling Social and Industrial Goals Stephane, Jacobzone |
| title_short | Pharmaceutical Policies in OECD Countries |
| title_sort | pharmaceutical policies in oecd countries reconciling social and industrial goals |
| title_sub | Reconciling Social and Industrial Goals |
| topic | Social Issues/Migration/Health |
| topic_facet | Social Issues/Migration/Health |
| url | https://doi.org/10.1787/323807375536 |
| work_keys_str_mv | AT jacobzonestephane pharmaceuticalpoliciesinoecdcountriesreconcilingsocialandindustrialgoals |